bio chat
“STRAND LB HELPS IN
IMPROVING THE QUALITY OF
LIFE OF THE PATIENT”
Strand Life Sciences has announced the launch of their Liquid Biopsy test
portfolio ‘Strand LB’ that provides highly sensitive detection of tumor traces
from a simple blood draw. In this part of the interview, Dr Vijay Chandru,
Chairman & Managing Director of the company shared the details on how it is a
powerful tool to detect early and precise indication of tumor presence or cancer
recurrence
40
BioVoiceNews | May 2017